Gleason Shane Thomas 4
4 · InspireMD, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
InspireMD, Inc.NSPR
Gleason Shane Thomas
Chief Commercial Officer
Transactions
- Award
Common Stock
[F1]2026-01-14+453,390→ 1,200,371 total
Footnotes (1)
- [F1]These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Signature
/s/ Michael Lawless, Attorney-in-Fact for Shane Gleason|2026-01-16